Search PubMed⌕ Search

Biomedical subjects

J Elston

Publications and source records attributed to J Elston.

28 records · Page 2Linked to original sources

The role of botulinum toxin in the management of sixth nerve palsy.

Fifty-five patients with sixth nerve palsy have been treated with Botulinum toxin injection to the antagonist medial rectus, either in isolation or in combination with rectus muscle surgery. Forty of these patients (72 per cent) obtained significant benefit from injection at some stage in their management. Botulinum toxin has a major role in conjunction with transposition muscle surgery for the treatment of complete unrecovered sixth nerve palsy. In less severe paresis, a functional cure may be obtained in a significant number of cases with the use of Botulinum toxin alone, 37 per cent in this series. No serious complications were observed. In view of the safety of this procedure it is reasonable to consider an injection of Botulinum toxin in any adult patient with a persisting sixth nerve palsy.

Abducens Nerve↗

Visual evoked potentials in dissociated vertical deviation: a reappraisal.

Pattern reversal and flash evoked potentials were recorded in 13 children with dissociated vertical deviation (DVD). No electrophysiological evidence was found to support the notion that patients with DVD have an anomalous (albinoid) projection of visual fibres originating from the temporal retina of each eye. However, DVD patients had significantly smaller monocular and binocular pattern evoked responses than age matched controls. Explanations are given for this finding and for the occipital VEP asymmetries reported by other workers.

Adolescent↗

Pattern- and flash-evoked potentials in patients with dissociated vertical deviation.

Pattern reversal and flash evoked potentials were recorded in 13 children with dissociated vertical deviation. We found no evidence of anomalous responses to pattern reversal half-field stimulation and no asymmetries in flash responses as reported to occur in albinism. However, we found that patients with dissociated vertical deviation had significantly smaller monocular and binocular pattern responses compared to a group of age-matched control subjects.

Adolescent↗

Treatment of sixth nerve palsy in adults with combined botulinum toxin chemodenervation and surgery.

This study reports the results of treating unrecovered sixth nerve palsy in adults with a combination of botulinum toxin and surgery. Twenty-two adults, 11 with unilateral and 11 with bilateral unrecovered sixth nerve palsy, were treated with injections of botulinum toxin to the contracted medial rectus followed by transposition surgery to the vertical rectus muscles. This management technique produced a satisfactory reduction in esotropia, averaging 46 prism diopters (PD), comparable with that achieved by conventional surgery in other series. The advantages of this form of treatment are discussed.

Abducens Nerve↗

Botulinum toxin therapy for squint.

Four hundred and five patients have been treated with injections of Botulinum neurotoxin A to extraocular muscles in the Botulinum Toxin Clinic at Moorfields Eye Hospital from November 1982 until the present. The indications and outcome of therapy are described and discussed.

Adolescent↗

Blepharospasm: a review of 264 patients.

The natural history and response to different treatments have been evaluated in 264 patients with blepharospasm. The mean age of onset was 55.8 years and there was a female preponderance of 1.8 to 1. Dystonia elsewhere was found in 78% of patients, usually in the cranial-cervical region, and appeared to follow a somatotopic progression. A family history of blepharospasm or dystonia elsewhere was found in 9.5% of cases, which suggests a genetic predisposition. Ocular lesions preceded the onset of blepharospasm in 12.1% of cases. The response to drugs was inconsistent, although initial improvement was experienced by one fifth of patients treated with anticholinergics. Twenty-nine bilateral facial nerve avulsion operations were performed with benefit in 27 cases; but recurrences appeared in 22, on average one year after surgery. Botulinum toxin injections were performed in 151 patients. Significant improvement was achieved in 118 cases. Mean duration of benefit was 9.2 weeks. Transient ptosis and diplopia were the commonest side effects.

Adolescent↗

Diplopia.

Diplopia may be a presenting symptom of a wide variety of ocular and neurological conditions. Careful questioning and examination will reveal the cause in many cases and may save the patient much unnecessary and expensive investigation.

Accommodation, Ocular↗

A simplified technique for the production of experimental aortic regurgitation.

A simple and effective method for the production of aortic incompetence in dogs is described. The instrument used in the procedure can be made easily and is robust. Controlled rupture of one or more of the three aortic valve cusps can be achieved without thoracotomy. There was no immediate operative mortality in the study and the time required to complete the procedure averaged 30 min. No evidence of healing of the cusp rupture could be found at necropsy even in dogs sacrificed 480 days after operation.

Animals↗

[Pharmacologic, surgical and infiltration of botulin toxin treatment in blepharospasm].

The response to different therapeutic methods was evaluated in a series of 264 patients with blepharospasm. The most effective drug therapy were anticholinergic agents, which resulted in the initial improvement of symptoms in 20% of treated patients. There was improvement in isolated cases treated with levodopa, dopaminergic agonists, neuroleptics, benzodiazepines and tricyclic antidepressants. Bilateral avulsion of the facial nerve was carried out in 29 patients; 27 of these (93%) improved. Spasms relapsed in 22 cases, after a mean period of 12 months. Myectomy of the orbicular muscle was performed in 8 patients. In only 2 cases some improvement was obtained. One hundred and fifty-one patients were treated with infiltrations of botulinum toxin A in the orbicular muscle. 78% of cases improved. The mean duration of the benefit of each injection was 9.2 weeks. The most common secondary effects were local (ptosis, diplopia) and transient.

Blepharospasm↗